From: Treatment of primary headache in children: a multicenter hospital-based study in France
Probable migraine | Migraine with aura | Migraine without aura | Other headaches | Total | |
---|---|---|---|---|---|
N = 50 | N = 44 | N = 195 | N = 98 | N = 387 | |
Acute headache treatments, n (%) | |||||
NSAIDS | 19 (38.0) | 26 (59.1) | 115 (59.0) | 49 (50.0) | 209 (54.0) |
Paracetamol | 40 (80.0) | 39 (88.6) | 162 (83.1) | 80 (81.6) | 321 (83.0) |
Ergot alkaloid | None | 2 (4.6) | 3 (1.5) | 1 (1.0) | 6 (1.6) |
Triptan | None | 1 (2.3) | 10 (5.1) | 1 (1.0) | 12 (3.1) |
Analgesics | 1 (2.0) | 2 (4.6) | 1 (0.5) | 1 (1.0) | 5 (1.3) |
None | 3 (6.0) | 1 (2.3) | 5 (2.6) | 10 (10.2) | 19 (4.9) |
Prophylactic treatments, n (%) | |||||
Antiserotonergics | 1 (2.0) | None | 12 (6.2) | 2 (2.0) | 15 (3.9) |
Tricyclics | None | None | None | 1 (1.0) | 1 (0.3) |
Beta blockers | None | None | 2 (1.0) | None | 2 (0.5) |
Ca channel blockers | None | None | 2 (1.0) | 2 (2.0) | 4 (1.0) |
Ergot alkaloids | 4 (8.0) | 2 (4.6) | 16 (8.2) | 5 (5.1) | 27 (7.0) |
Antiepileptic drugs | 1 (2.0) | None | None | 1 (1.0) | 2 (0.5) |
No prophylaxis | 45 (90.0) | 42 (95.5) | 170 (87.2) | 91 (92.9) | 348 (89.9) |